AARTI DRUGS LTD (AARTIDRUGS.NS) Financials
AARTIDRUGS.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 23.5 billion | 11.4 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 24.2 billion | 12.3 billion |
AARTIDRUGS.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 253.2 million | ? |
| 2023-09-30 | 252.2 million | ? |
| 2023-06-30 | 252.0 million | ? |
| 2023-03-31 | 250.0 million | ? |
AARTIDRUGS.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 366.7 million |
| 2023-09-30 | 395.9 million |
| 2023-06-30 | 479.7 million |
| 2023-03-31 | 560.9 million |
AARTIDRUGS.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 249.9 million | 2.1 billion | 19.3 million |
| 2023-06-30 | 211.7 million | - | - |
| 2023-03-31 | 211.7 million | 2.1 billion | 23.9 million |
AARTIDRUGS.NS Shares Outstanding
AARTIDRUGS.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 1.1 billion | - | 254.5 million | - |
| 2023-06-30 | - | - | 254.7 million | - |
| 2023-03-31 | 1.6 billion | 77.5 million | 1.1 billion | 11.7 million |
AARTIDRUGS.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 6.1 billion | 4.1 billion |
| 2023-09-30 | 6.4 billion | 4.3 billion |
| 2023-06-30 | 6.6 billion | 4.5 billion |
| 2023-03-31 | 7.4 billion | 5.2 billion |
AARTIDRUGS.NS
Price: ₹492.40
Dividend Yield: 0.00%
Forward Dividend Yield: 0.20%
Payout Ratio: 5.11%
Dividend Per Share: 1.00 INR
Earnings Per Share: 19.58 INR
P/E Ratio: 27
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 46.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 3